Background: End-of-life (EOL) care quality and health care costs for patients with cancer are critical issues for health care providers. We evaluated the effect of the timing of hospice care referral on care quality and health care costs for patients with lung cancer in their EOL.
Methods: Using claims data from the Taiwan National Health Insurance Research Database, we analyzed EOL care quality indicators and health care costs in the last month of life for patients with advanced lung cancer who died during 1997-2011.
Results: In total, 566 adult patients with lung cancer who received hospice care were enrolled. The appropriate timing of hospice referral for improving care quality was more than 2 months before death. Compared with patients with a short hospice stay before death (<2 months), those with a longer hospice stay (>2 months) had less proportions of one or more quality indicators of EOL care (p=0.002), fewer in-hospital deaths (p<0.001), as well as lower mean health care costs during the last month of life (NT$43,642 ± 4,997 vs. NT$64,560 ± 2,456, p<0.001), but more than one hospitalization in the last month of life (p=0.048).
Conclusion: Our results suggest that the appropriate timing of hospice referral for patients with advanced lung cancer was more than 2 months before death. Patients with more than 2 months of hospice service had improved EOL care and 32.4% lower health care costs in their last month of life than those with less than 2 months of hospice service.